Cargando…
Drug Vulnerabilities and Disease Prognosis Linked to the Stem Cell-Like Gene Expression Program Triggered by the RHO GTPase Activator VAV2 in Hyperplastic Keratinocytes and Head and Neck Cancer
SIMPLE SUMMARY: Head and neck squamous cell carcinoma are epithelial tumors with a very poor prognosis. They are also in high need of new targeted and immune-based therapeutics to limit tumor recurrence and improve long-term survival. The poor prognosis of patients with head and neck tumors is usual...
Autores principales: | Lorenzo-Martín, Luis Francisco, Menacho-Márquez, Mauricio, Bustelo, Xosé R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563609/ https://www.ncbi.nlm.nih.gov/pubmed/32899210 http://dx.doi.org/10.3390/cancers12092498 |
Ejemplares similares
-
The Rho guanosine nucleotide exchange factors Vav2 and Vav3 modulate epidermal stem cell function
por: Lorenzo-Martín, L. Francisco, et al.
Publicado: (2022) -
The Rho Exchange Factors Vav2 and Vav3 Favor Skin Tumor Initiation and Promotion by Engaging Extracellular Signaling Loops
por: Menacho-Márquez, Mauricio, et al.
Publicado: (2013) -
The Rho GTPase exchange factor Vav2 promotes extensive age-dependent rewiring of the hair follicle stem cell transcriptome
por: Lorenzo-Martín, L. Francisco, et al.
Publicado: (2023) -
Vav3-deficient Mice Exhibit a Transient Delay in Cerebellar Development
por: Quevedo, Celia, et al.
Publicado: (2010) -
New Functions of Vav Family Proteins in Cardiovascular Biology, Skeletal Muscle, and the Nervous System
por: Rodríguez-Fdez, Sonia, et al.
Publicado: (2021)